Texas Tech University
100
13
16
71
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.0%
5 terminated/withdrawn out of 100 trials
93.4%
+6.9% vs industry average
3%
3 trials in Phase 3/4
8%
6 of 71 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (100)
Tirzepatide Impact Assessment Study
Role: lead
Strength Training and Resveratrol
Role: lead
Heat and Exercise in Aging as Therapy (HEAT)
Role: lead
Psilocybin for Prolonged Grief Disorder
Role: collaborator
Naltrexone for Prolonged Grief Disorder
Role: lead
Telehealth to Improve Quality of Life in Persons Living in Rural Texas
Role: lead
ACT for Individuals With MNCD and Their Care Partners
Role: lead
Pilot Testing a Novel Approach to Pediatric Obesity Treatment
Role: lead
Telehealth to Reduce Mental Health in Family Caregivers
Role: lead
Study of Patients Being Treated With Anti-obesity Medication
Role: lead
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
Role: lead
Comparison Between the Health Effects of an AI-driven Model With Those of Human Professional Guidelines for the Treatment of Obesity
Role: lead
EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition
Role: collaborator
Food Addiction and Hormone Study
Role: lead
Investigating a Brief Virtual Seminar Series for Parents of Children Ages 2-12
Role: lead
Investigating a Brief Virtual Seminar Series for Parents of Teens Ages 13-17
Role: lead
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants
Role: collaborator
Improving Mental Health for Care Partners of Persons With AD/ADRD
Role: lead
Effects of Semantically Irrelevant Virtual Reality Experience on Memory and Emotion
Role: lead
L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD
Role: collaborator